An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 16,039 | 12,476 | 11,770 | 10,333 | 7,683 |
| Operating Income | -16,039 | -12,476 | -11,770 | -10,333 | -7,683 |
| Other Income | 716 | 634 | 431 | 213 | 28 |
| Pre-tax Income | -15,323 | -11,842 | -11,339 | -10,120 | -7,655 |
| Net Income Continuous | -15,323 | -11,842 | -11,339 | -10,120 | -7,655 |
| Net Income | $-15,323 | $-11,842 | $-11,339 | $-10,120 | $-7,655 |
| EPS Basic Total Ops | -0.79 | 1.31 | -0.59 | -0.53 | -2.98 |
| EPS Basic Continuous Ops | -0.79 | 0.85 | -0.59 | -0.53 | -2.41 |
| EPS Diluted Total Ops | -0.79 | 1.31 | -0.59 | -0.53 | -2.98 |
| EPS Diluted Continuous Ops | -0.79 | 0.85 | -0.59 | -0.53 | -2.41 |
| EBITDA(a) | $-16,474 | $-12,851 | $-12,015 | $-10,406 | $-7,682 |